Trial intelligence / Profile preview

Intralesional Sodium Thiosulfate for Calcinosis Cutis

NCT03639779Phase 4Terminated

Sponsor
University of Central Florida
Start
Nov 2018
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sodium thiosulfate in calcinosis cutis, sponsored by University of Central Florida. Started Nov 2018; status: terminated.

02

Drugs

sodium thiosulfate
03

Conditions

calcinosis cutis

Beyond the preview

Go deeper on NCT03639779.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03639779.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call